Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | € 119.26M | € 98.50M | € 86.64M | € 81.25M | € 126.30M |
Total Assets | € 1.97B | € 1.90B | € 1.89B | € 1.94B | € 1.95B |
Total Debt | € 661.74M | € 627.24M | € 647.70M | € 649.24M | € 768.93M |
Net Debt | € 542.48M | € 528.73M | € 561.06M | € 567.99M | € 642.64M |
Total Liabilities | € 1.48B | € 1.43B | € 1.43B | € 1.49B | € 1.55B |
Stockholders Equity | € 474.03M | € 454.69M | € 445.90M | € 435.90M | € 387.74M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |